Updated:
Pegasus Investment
Pegasus Investment is an SEC-registered investment adviser with $30 million in regulatory assets under management.
Pegasus Investment
Pegasus Investment is an SEC-registered investment adviser with $30 million in regulatory assets under management. The firm manages $2 million on a discretionary basis. It has 1 employee and 1 investment adviser.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Frequently asked questions
How does Pegasus Investment source deals within China's private equity market?
Without public disclosures, the firm's sourcing channels remain undocumented. Domestic Chinese private equity firms of this profile typically source through a combination of government relationships, industry association networks, and referrals from portfolio company founders — channels that are significantly relationship-dependent and not visible to external allocators.
Does Pegasus Investment accept foreign LP capital?
There is no evidence that Pegasus Investment operates any offshore vehicles or holds a qualified foreign limited partner (QFLP) license. Based on its purely domestic website and RMB-denominated fund structure, the firm likely limits its LP base to Chinese institutional investors, government guidance funds, and domestic high-net-worth individuals.
How does regulatory risk in China affect the firm's strategy?
As an onshore RMB manager, Pegasus Investment is directly subject to the Asset Management Association of China's (AMAC) registration and reporting requirements, and its portfolio companies operate entirely under China's domestic regulatory framework. The 2021–2023 regulatory tightening across technology, education, and healthcare sectors reshaped exit pathways for growth-stage investors; firms without offshore diversification must build their investment theses entirely around sectors that align with current policy priorities.
What distinguishes growth equity from venture capital in the Chinese market?
Growth equity in China typically targets companies with proven revenue models and clear paths to profitability, in contrast to venture capital's focus on pre-revenue or early-revenue technology startups. Growth-stage investors often take minority stakes and aim for exits via domestic A-share IPOs or trade sales to strategic acquirers, sectors where the STAR Board and ChiNext have provided domestic listing venues since 2019–2020.
Which sectors does Pegasus Investment avoid?
No explicit exclusion list is publicly available. However, Chinese growth-equity managers broadly reduced exposure to consumer internet and private tutoring during the 2021–2022 regulatory crackdowns, and the current policy environment favors advanced manufacturing, hard technology, healthcare innovation, and enterprise digitization — sectors where future regulatory risk is perceived as lower.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: